AR127127A1 - NUEVOS DERIVADOS DE PIRIDODIAZEPINAS COMO PAM DE GABAA g1 - Google Patents
NUEVOS DERIVADOS DE PIRIDODIAZEPINAS COMO PAM DE GABAA g1Info
- Publication number
- AR127127A1 AR127127A1 ARP220102559A ARP220102559A AR127127A1 AR 127127 A1 AR127127 A1 AR 127127A1 AR P220102559 A ARP220102559 A AR P220102559A AR P220102559 A ARP220102559 A AR P220102559A AR 127127 A1 AR127127 A1 AR 127127A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- pyridodiazepine
- gabaa
- pam
- derivatives
- Prior art date
Links
- VCJCULBSFIZKLM-UHFFFAOYSA-N 1h-pyrido[3,2-c]diazepine Chemical class N1N=CC=CC2=NC=CC=C12 VCJCULBSFIZKLM-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 208000012902 Nervous system disease Diseases 0.000 abstract 2
- 208000025966 Neurological disease Diseases 0.000 abstract 2
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invención proporciona compuestos heterocíclicos novedosos que tienen la fórmula general (1), y sales farmacéuticamente aceptables de estos, en donde las variables son como se describe en la presente. También se proporcionan composiciones farmacéuticas que incluyen los compuestos, procesos de elaboración de los compuestos y métodos para usar los compuestos como medicamentos, en particular, métodos para usar los compuestos para el tratamiento o prevención de trastornos neurológicos agudos, trastornos neurológicos crónicos y/o trastornos cognitivos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21198735 | 2021-09-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR127127A1 true AR127127A1 (es) | 2023-12-20 |
Family
ID=77924305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP220102559A AR127127A1 (es) | 2021-09-24 | 2022-09-22 | NUEVOS DERIVADOS DE PIRIDODIAZEPINAS COMO PAM DE GABAA g1 |
Country Status (10)
Country | Link |
---|---|
US (2) | US20230109111A1 (es) |
EP (1) | EP4405356A1 (es) |
KR (1) | KR20240065086A (es) |
CN (1) | CN117957227A (es) |
AR (1) | AR127127A1 (es) |
AU (1) | AU2022351080A1 (es) |
CA (1) | CA3229125A1 (es) |
IL (1) | IL310444A (es) |
TW (1) | TW202322804A (es) |
WO (1) | WO2023046877A1 (es) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100865410B1 (ko) * | 2002-03-28 | 2008-10-24 | 위시스 테크놀로지 파운데이션, 인크. | 진정 및 운동실조 효과가 감소된 항불안제 |
-
2022
- 2022-09-22 AR ARP220102559A patent/AR127127A1/es unknown
- 2022-09-23 TW TW111136044A patent/TW202322804A/zh unknown
- 2022-09-23 KR KR1020247008988A patent/KR20240065086A/ko unknown
- 2022-09-23 CN CN202280062998.0A patent/CN117957227A/zh active Pending
- 2022-09-23 AU AU2022351080A patent/AU2022351080A1/en active Pending
- 2022-09-23 IL IL310444A patent/IL310444A/en unknown
- 2022-09-23 WO PCT/EP2022/076467 patent/WO2023046877A1/en active Application Filing
- 2022-09-23 US US17/934,769 patent/US20230109111A1/en not_active Abandoned
- 2022-09-23 EP EP22793720.8A patent/EP4405356A1/en active Pending
- 2022-09-23 CA CA3229125A patent/CA3229125A1/en active Pending
-
2024
- 2024-02-14 US US18/441,558 patent/US20240270744A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4405356A1 (en) | 2024-07-31 |
IL310444A (en) | 2024-03-01 |
US20240270744A1 (en) | 2024-08-15 |
CN117957227A (zh) | 2024-04-30 |
TW202322804A (zh) | 2023-06-16 |
US20230109111A1 (en) | 2023-04-06 |
WO2023046877A1 (en) | 2023-03-30 |
AU2022351080A1 (en) | 2024-02-15 |
CA3229125A1 (en) | 2023-03-30 |
KR20240065086A (ko) | 2024-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP20069418A (es) | Compuestos heterocíclicos como inmunomoduladores | |
CO2019007863A2 (es) | Derivados de benzooxazol como inmunomoduladores | |
CO2018011064A2 (es) | Inhibidores de bromodominios | |
CY1122046T1 (el) | Δικυκλικα ετεροκυκλικα παραγωγα ως αναστολεις βρομοτομεων | |
CU20210015A7 (es) | COMPUESTOS DE PIRAZOLO [3.4-b] PIRIDINA COMO INHIBIDORES DE CINASAS TAM Y MET | |
UY27234A1 (es) | Inhibidores novedosos de tirosina cinasa | |
CO2024000588A2 (es) | Composiciones y métodos para la inhibición de ras | |
AR085219A1 (es) | 6-cicloalquil-pirazolopirimidinonas para el tratamiento de trastornos del snc | |
CU20090184A7 (es) | Compuestos amino-heterocíclicos | |
UY28691A1 (es) | Derivados de difenilazetidona | |
CR20190361A (es) | Dendrímeros terapéuticos | |
SV2017005354A (es) | Derivados de quinolizinona como inhibidores de pi3k | |
CY1124346T1 (el) | ΠΑΡΑΓΩΓΑ ΧΡΩΜΑΝΙΟΥ, ΙΣΟΧΡΩΜΑΝΙΟΥ ΚΑΙ ΔΙΥΔΡΟΪΣΟΒΕΝΖΟΦΟΥΡΑΝΙΟΥ ΩΣ mGluR2-APNHTIKOI ΑΛΛΟΣΤΕΡΙΚΟΙ ΔΙΑΜΟΡΦΩΤΕΣ, ΣΥΝΘΕΣΕΙΣ, ΚΑΙ ΧΡΗΣΗ ΑΥΤΩΝ | |
CO2019001181A2 (es) | Compuestos de heteroarilcarboxamida como inhibidores de ripk2 | |
CO2022011258A2 (es) | Pirazolo-pirimidinas sustituidas y usos de las mismas | |
CO2024003953A2 (es) | Derivados de benzodiazepina como moduladores alostéricos positivos del receptor de gaba a gamma1 | |
CL2024000239A1 (es) | Derivados de piridina sustituida como inhibidores de sarm1 | |
AR125457A2 (es) | Compuestos inhibidores dobles de magl y faah y composición farmacéutica | |
UY38665A (es) | Agentes antiproliferativos para el tratamiento de pah | |
CL2022000875A1 (es) | Inhibidores del factor d del complemento para administración oral | |
AR127470A1 (es) | Inhibidores de lrrk2 | |
CL2022000889A1 (es) | Inhibidores del factor d del complemento para administración oral | |
CL2023001244A1 (es) | Derivados de carboxamida heteroaromática como inhibidores de la calicreína plasmática | |
CL2023001339A1 (es) | Un inhibidor de magl. | |
CO2022014499A2 (es) | Moduladores de nlrp3 |